Lockheed Martin Corporation v. Robert M. Walker, Acting Secretary of the Army

155 F.3d 572, 42 Cont. Cas. Fed. 77,322
CourtCourt of Appeals for the Federal Circuit
DecidedJune 24, 1998
Docket20-104
StatusUnpublished
Cited by4 cases

This text of 155 F.3d 572 (Lockheed Martin Corporation v. Robert M. Walker, Acting Secretary of the Army) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lockheed Martin Corporation v. Robert M. Walker, Acting Secretary of the Army, 155 F.3d 572, 42 Cont. Cas. Fed. 77,322 (Fed. Cir. 1998).

Opinion

155 F.3d 572

42 Cont.Cas.Fed. (CCH) P 77,322

NOTICE: Federal Circuit Local Rule 47.6(b) states that opinions and orders which are designated as not citable as precedent shall not be employed or cited as precedent. This does not preclude assertion of issues of claim preclusion, issue preclusion, judicial estoppel, law of the case or the like based on a decision of the Court rendered in a nonprecedential opinion or order.
LOCKHEED MARTIN CORPORATION, Appellant,
v.
Robert M. WALKER, Acting Secretary of the Army, Appellee.

No. 98-1046.
June 24, 1998.

Before NEWMAN, Circuit Judge, SKELTON, Senior Circuit Judge, and LOURIE, Circuit Judge.

DECISION

LOURIE, Circuit Judge.

Lockheed Martin Corporation appeals from the final decision of the Armed Services Board of Contract Appeals denying its claim for an equitable adjustment in its production contract with the government. Loral Aerospace Corp., ASBCA Nos. 46373, 47388, 48649, 97-2 BC p 29,128 (Jul. 22, 1997). Because Lockheed has not shown that the Board misconstrued the contract or that the Board's decision was not supported by substantial evidence, we affirm.

DISCUSSION

Lockheed1 entered into a contract with the government to produce missile guidance sections. The contract contained a Preproduction and Production Evaluation Requirements (PPE) clause, the intent of which is set forth in introductory paragraph (a), which states in relevant part:

This preproduction evaluation clause is intended to

(i) identify the problem of possible technical data deficiencies[;]

(ii) provide for the contractor[']s responsibility to review the Technical Data Package[2 [TDP] to identify and determine corrections of these deficiencies necessary to permit quantity production;

(iii) require reporting of such deficiencies and corrections to the government; and

(iv) to provide that the identification of such deficiencies and the necessary correction thereof shall not be cause under this contract for any price increase or revision in the delivery schedule.

(paragraphing and emphasis added). The introductory paragraph concludes that "[t]his clause is not intended to place upon the contractor any design responsibility under this contract except as provided herein." (emphasis added).

Paragraph (b) in the PPE defines that clause's scope, and specifies that:

Prior to, or in conjunction with [pre-production planning], and throughout the production phases of the contract, the contractor shall perform a detailed evaluation of all technical data associated with this contract. Such evaluation shall include ... analysis, identification, and recommended correction of any deficiencies in such data which the contractor considers necessary to assure that:

(1) The contract items ... can be produced, fabricated, assembled, and operated in complete accordance with the requirements of this contract and such technical data, corrected as required by this clause....

(2) The PPE clause shall provide for the complete resolution of deficiencies which:

(a) may have been overlooked during the development program such as typographical errors, and including those associated with conflicts of technical data within the TDP, and including completeness, correctness and clarity of the TDP.

(b) are attributable to tolerance stackup and no-fit dimension conditions.

....

(l) are associated with increasing the percentage yield or rate of production to meet quantity and schedule requirements specified within this contract.

The parties agree that the PPE clause transferred to Lockheed the risk of identifying and correcting the deficiencies listed in paragraph (b)(2). The issue in this case is what that paragraph means.

After production was undertaken, it became clear that the TDP contained certain design deficiencies. As a result, the sections produced by Lockheed performed poorly and were of very low yield. Lockheed alleges that it spent an extra $25 million overcoming certain of these design deficiencies (14 in all) during production, and sought price increases therefor. After unsuccessfully requesting that the contracting officer approve this sum as an equitable adjustment, Lockheed appealed to the Board.

The Board denied Lockheed's claim, finding that each asserted deficiency was covered by the PPE clause, and that the risk of overcoming such deficiencies therefore rested upon Lockheed. Specifically, the Board determined that the asserted deficiencies were covered by various combinations of clauses (b)(2)(a), (b) and (l).3 See slip op. at 8-14. The Board also rejected parol evidence proffered by Lockheed that purported to show that the parties intended the contract to be "build to print," apparently meaning that Lockheed could blindly follow the TDP without liability for poor product performance, and accordingly that the PPE clause covered only "minor" TDP errors and not "major" design changes. Id. at 18. The Board also found relevant that Lockheed considered the risk shifted to it by the PPE clause to be significant. Id. at 18-19.

Lockheed appealed to this court. We have jurisdiction pursuant to 28 U.S.C. § 1295(a)(10) (1994). The standard under which we review a decision of the Board is dictated by the Contract Disputes Act, which provides in relevant part:

the decision of the agency board on any question of law shall not be final or conclusive, but the decision on any question of fact shall be final and conclusive and shall not be set aside unless the decision is fraudulent, or arbitrary, or capricious, or so grossly erroneous as to necessarily imply bad faith, or if such decision is not supported by substantial evidence.

41 U.S.C. § 609(b) (1994). We review questions of law, including contract interpretation, de novo. See Grumman Data Sys. Corp. v. Dalton, 88 F.3d 990, 997 (Fed.Cir.1996). Notwithstanding this lack of deference concerning questions of law, "legal interpretations by tribunals having expertise are helpful to us, even if not compelling." Erickson Air Crane Co. v. United States, 731 F.2d 810, 814 (Fed.Cir.1984).

Lockheed argues that the Board misconstrued the scope of the PPE clause. Lockheed asserts that the PPE clause transferred to it responsibility for resolving only the limited listed deficiencies of paragraph (b)(2), but that the Board's overly-broad construction of the scope of those provisions, particularly clauses (b)(2)(a) and (l), improperly transferred all design responsibility to it. Lockheed also asserts that the Board erred in failing to consider the substance of the negotiations which led to the execution of the contract, evidence which Lockheed submits is indicative of the parties' intent to limit Lockheed's liability for correcting design deficiencies.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
876 F. Supp. 2d 295 (S.D. New York, 2012)
In Re Gabapentin Patent Litigation
395 F. Supp. 2d 164 (D. New Jersey, 2005)
In Re Intercat, Inc.
247 B.R. 911 (S.D. Georgia, 2000)
WR Grace & Co.-Conn. v. Intercat, Inc.
60 F. Supp. 2d 316 (D. Delaware, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
155 F.3d 572, 42 Cont. Cas. Fed. 77,322, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lockheed-martin-corporation-v-robert-m-walker-acting-secretary-of-the-cafc-1998.